Transmedics Group Stock Performance
| TMDX Stock | USD 57.20 0.82 1.41% |
The entity has a beta of -0.26, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning TransMedics are expected to decrease at a much lower rate. During the bear market, TransMedics is likely to outperform the market. At this point, TransMedics Group has a negative expected return of -1.06%. Please make sure to validate TransMedics' maximum drawdown, as well as the relationship between the daily balance of power and period momentum indicator , to decide if TransMedics Group performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days TransMedics Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
Actual Historical Performance (%)
One Day Return (1.41) | Five Day Return (12.15) | Year To Date Return (13.98) | Ten Year Return 155.81 | All Time Return 155.81 |
1 | These 4 Measures Indicate That TransMedics Group Is Using Debt Reasonably Well | 11/20/2024 |
2 | Disposition of 6750 shares by Basile Edward M of TransMedics at 28.12 subject to Rule 16b-3 | 11/25/2024 |
3 | Disposition of 300 shares by Hassanein Waleed H of TransMedics at 135.04 subject to Rule 16b-3 | 11/29/2024 |
4 | Why TransMedics Stock Plummeted Today | 12/03/2024 |
5 | TransMedics Group Inc to Present at J.P. Morgan Healthcare Conference | 12/23/2024 |
6 | TransMedics Group Inc Shares Up 3.5 percent on Jan 7 | 01/07/2025 |
7 | TransMedics Group Inc Under Investigation for Potential Securities Law Violations | 01/10/2025 |
8 | Rosen Law Firm Encourages TransMedics Group, Inc. Investors to Inquire About Securities Class Action Investigation TMDX | 01/13/2025 |
9 | TransMedics Group Inc Faces Allegations of Fraud and Misconduct | 01/14/2025 |
10 | TransMedics Group, Inc. Announcement If You Have Suffered Losses in TransMedics Group, Inc. ... | 01/15/2025 |
11 | TransMedics faces fraud, organ trafficking accusations from activist short seller | 01/16/2025 |
| Begin Period Cash Flow | 201.7 M |
TransMedics |
TransMedics Relative Risk vs. Return Landscape
If you would invest 12,448 in TransMedics Group on October 20, 2024 and sell it today you would lose (6,728) from holding TransMedics Group or give up 54.05% of portfolio value over 90 days. TransMedics Group is currently does not generate positive expected returns and assumes 5.7846% risk (volatility on return distribution) over the 90 days horizon. In different words, 51% of stocks are less volatile than TransMedics, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
TransMedics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for TransMedics' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as TransMedics Group, and traders can use it to determine the average amount a TransMedics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1836
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | TMDX |
Estimated Market Risk
| 5.78 actual daily | 51 51% of assets are less volatile |
Expected Return
| -1.06 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.18 actual daily | 0 Most of other assets perform better |
Based on monthly moving average TransMedics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of TransMedics by adding TransMedics to a well-diversified portfolio.
TransMedics Fundamentals Growth
TransMedics Stock prices reflect investors' perceptions of the future prospects and financial health of TransMedics, and TransMedics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on TransMedics Stock performance.
| Return On Equity | 0.19 | ||||
| Return On Asset | 0.0284 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.04 % | ||||
| Current Valuation | 2.14 B | ||||
| Shares Outstanding | 33.56 M | ||||
| Price To Book | 9.28 X | ||||
| Price To Sales | 4.85 X | ||||
| Revenue | 241.62 M | ||||
| Gross Profit | 237.99 M | ||||
| EBITDA | (7.6 M) | ||||
| Net Income | (25.03 M) | ||||
| Cash And Equivalents | 204.46 M | ||||
| Cash Per Share | 6.41 X | ||||
| Total Debt | 515.95 M | ||||
| Debt To Equity | 0.36 % | ||||
| Current Ratio | 12.11 X | ||||
| Book Value Per Share | 6.25 X | ||||
| Cash Flow From Operations | (13.03 M) | ||||
| Earnings Per Share | 0.92 X | ||||
| Market Capitalization | 1.95 B | ||||
| Total Asset | 706.05 M | ||||
| Retained Earnings | (503.7 M) | ||||
| Working Capital | 455.72 M | ||||
About TransMedics Performance
Evaluating TransMedics' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if TransMedics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if TransMedics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 212.13 | 201.52 | |
| Return On Tangible Assets | (0.03) | (0.03) | |
| Return On Capital Employed | (0.04) | (0.04) | |
| Return On Assets | (0.03) | (0.03) | |
| Return On Equity | (0.21) | (0.20) |
Things to note about TransMedics Group performance evaluation
Checking the ongoing alerts about TransMedics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for TransMedics Group help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| TransMedics Group generated a negative expected return over the last 90 days | |
| TransMedics Group has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 241.62 M. Net Loss for the year was (25.03 M) with profit before overhead, payroll, taxes, and interest of 237.99 M. | |
| TransMedics Group currently holds about 204.46 M in cash with (13.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.41. | |
| Over 97.0% of the company shares are owned by institutional investors | |
| Latest headline from massdevice.com: TransMedics faces fraud, organ trafficking accusations from activist short seller |
- Analyzing TransMedics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether TransMedics' stock is overvalued or undervalued compared to its peers.
- Examining TransMedics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating TransMedics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of TransMedics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of TransMedics' stock. These opinions can provide insight into TransMedics' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for TransMedics Stock Analysis
When running TransMedics' price analysis, check to measure TransMedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TransMedics is operating at the current time. Most of TransMedics' value examination focuses on studying past and present price action to predict the probability of TransMedics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TransMedics' price. Additionally, you may evaluate how the addition of TransMedics to your portfolios can decrease your overall portfolio volatility.